Who backs Ambagon Therapeutics?
13 investors| Investor | Type |
|---|---|
| RA Capital Management | Asset manager |
| Citadel Enterprise Americas | Hedge fund |
| AbbVie Ventures | — |
| Blackwell Partners | — |
| Curie.Bio | — |
| Droia Ventures | — |
| Eindhoven University of Technology | — |
| Inkef | — |
| LifeSciences@Work | — |
| MRL Ventures Fund | — |
| + 3 more investors · a free account shows the complete list | |
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns
Membership and data by Private Market View
Ambagon Therapeutics investors
13 investors are on record for Ambagon Therapeutics, including RA Capital Management, Citadel Enterprise Americas, AbbVie Ventures and Blackwell Partners. The early-stage round in Jan 2025 drew 4 investors.
Free account
More of Ambagon Therapeutics with a free account
- ·The complete investor list: 13 names
- ·Watch Ambagon Therapeutics: the Monday email on marks, rounds and moves
For fundraisers
Work this list, don’t just read it
These 13 firms already write checks for companies like Ambagon Therapeutics in drug discovery. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.
Membership and data by Private Market View